Canadian fourth gen Rob Sobey has announced he is retiring as chief executive and president of Lawton's Drugs, an operating division of the eponymous family business, Sobeys Inc.
Sobey, 47, who has worked in the family firm for 32 years, says his decision will allow him more time to focus on his philanthropy and outside business interests, which include his role on the board of private investment Seafort Capital, alongside his father, Donald.